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Background: Klebsiella oxytoca is an opportunistic pathogen which damages intestinal epithelium
through producing cytotoxin tilivalline. This toxin plays a role in the pathogenesis of bacteria and is the
main virulence factor which leads to antibiotic-associated hemorrhagic colitis progress.
Materials and methods: In this study, we collected a total of 75 K. oxytoca strains isolated from the stool,
urine, blood, wounds, and sputum and evaluated them in terms of the production of toxins; we detected
their cytotoxic effects on HEp-2 cells.
Results: Of all the isolates, ﬁve K. oxytoca strains isolated from the stool cultures, two strains isolated
from the blood cultures, one strains isolated from the wound cultures, and one strains isolated from the
urine cultures had cytotoxic effects on HEp-2 cells. The strains isolated from sputum cultures had no
cytotoxic effects on HEp-2 cells.
Conclusions: In the current study, the majority of strains isolated from the stool of the patients included
cytopathic effects on HEp-2 cells.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
K. oxytoca is a member of the Enterobacteriaceae family. This
bacterium is non-motile, Gram-negative, rod-shaped and is
considered as an opportunistic pathogen. Currently, K. oxytoca is
considered as a clinically signiﬁcant pathogen which is associated
with infections in hospitalized patients, including children, new-
borns, and individual with immune deﬁciency. K. oxytoca as a
remarkable opportunistic pathogen can play an important role for
the generation of various infections acquired in a hospital and
community. This bacterium is usually isolated from patients with
Septicemia, bacteremia, septic arthritis, soft-tissue infections,
cholecystitis, urinary tract infections, and most recently it has beencrobiology, School of Public
MS), Keshavarz Boulevard,
oltan-Dallal).also isolated from babies with colic [1].
Studies have shown that K. oxytoca can demonstrate its patho-
genesis via producing cytotoxin in human. K. oxytoca strains asso-
ciated with the colitis and mucosal skin infections in humans are
able to produce cytotoxin, which may be somewhat due to the
pathogenesis of this bacterium [2]. The feature of this cytotoxinwas
introduced in 1989 and 1992, when it observed that this bacterium
could round and kill the cell lines of HEp-2, HeLa, CHO, and Vero
in vitro [3,4]. In addition, as it was reported, this cytotoxin was
sensitive to heat, resistant to digestion by proteinase, had low
molecular weight, and its molecular formula was C8H15O4N3 [5].
Recently, this non-protein cytotoxin has been also called Tilivalline
(TLV) which is a member of pyrrolobenzodiazepine (PBD) family. It
is a nonribosomal peptide enterotoxin and is introduced as a new
class of cytotoxic intestinal bacteria [6]. In addition to K. oxytoca
strains, Micrococcus and Streptomyces strains are also able to pro-
duce Tilivalline cytotoxin [7]. Tilivalline is the only pyrrolobenzo-
diazepine (PBD) that is produced in the microbiota of human gut
and can disturb the intestinal epithelial barrier via the induction of
Fig. 1. Toxin negative K. oxytoca ATCC13182 supernatants on HEp-2 cell cultures.
M. Validi et al. / Microbial Pathogenesis 113 (2017) 1e42apoptosis and reduction of epithelial resistance [6]; as a result,
PBDs are known as altered metabolites of acinetobacter DNA [8].
K. oxytoca is recognized as one of the major causes of antibiotic-
associated hemorrhagic colitis (AAHC) in adolescents and adults
[9,10]. Researchers have recently discovered the how colitis is
caused by molecular mechanisms of K. oxytoca. Cytotoxin is one of
the important pathogenic factors, which plays a role in the viru-
lence of this bacterium. Cytotoxin is associated with the patho-
genesis of K. oxytoca [10,11]. The cytotoxic effects on epithelial cells
of the human are not observed in other strains of Klebsiella spp and
are only observed in K. oxytoca strains. This study aimed to identify
toxin-producing K. oxytoca strains isolated from clinical samples by
HEp-2 cell culture.
2. Materials and methods
2.1. Bcterial strains
A total of 75 strains of K. oxytoca were collected from several
hospitals in Tehran from 2015 to 2016. K. oxytoca strains were
isolated from 3750 clinical samples, including stool, blood, urine,
sputum, and wounds. In this study, a strain of K. oxytoca was also
isolated from the stool culture of a patient with diarrhea who was
suspected to Clostridium difﬁcile.
To identify the strains of K. oxytoca, we used morphology of
colonies on MacConkey agar (Merck, German), and the standard
microbiological tests. In addition, we used PCR to verify the isolates
of K. oxytoca by identiﬁcation of pehx gene.
2.2. Veriﬁcation of K. oxytoca isolates
All bacterial strains which underwent standard microbiological
tests in microbiology laboratories and were detected as K. oxytoca
strains were also detected and veriﬁed by PCR through ampliﬁca-
tion of Polygalacturonase speciﬁc gene (pehX).
2.3. Molecular detection of pehX gene
Genomic DNA of K. oxytoca isolates was obtained through
boiling two or three colonies in 500 ml of distilled water for 10 min
which were then centrifuged for 10 min at 10000 rpm. The su-
pernatants was used as the template for ampliﬁcation. To identify
pehX gene, forward primer PEH C and reverse primer PEH D, with
the following sequences, were used: forward primer PEH C (5 0GAT
ACG GAG TAT GCC TTT ACG GTG -30), reverse primer PEH D (50- TAG
CCT TTA TCA AGC GGA TAC TTG -3 0) [11,12]. PCR reaction was
performed in a ﬁnal volume of 20 ml. To perform each PCR reaction,
we used 10 mL master mix (Ampliqon, Denmark), 0. 5 ml forward
Primer 10 pmol (Bioneer, Daejeon, Korea), 0. 5 ml reverse Primer
10 pmol (Bioneer, Daejeon, Korea), 8. 5 ml distilled water, and 50 ng
of bacterial DNA.
PCR reaction was performed in a thermocycler (PEQLAB, Ger-
many) with an initial denaturation at 95 C for 5 min; and 35 cycles
including denaturation steps at 94 C for 45 s, the annealing at 52 C
for 45 s, the extention at 72 C for 45 s, and ﬁnal extention at 72 C
for 10 min. The electrophoresis of PCR product was performed in a
1% agarose gel. The gel was stained using ethidium bromide
(50 mg/L), and it was detected by Gel Doc (GVM20model syngene).
2.4. 4. Cytotoxin tissue culture assay
The cytotoxicity assays of K. oxytoca strains were performed
using previously described methods [10,13]. In brief, HEP-2 cell line
(ATCC CCL-23) was used for screening this cytotoxin. A 1:1 dilution
of the ﬁltered supernatant from culture of K. oxytoca strains withPBS was added to the each well of a 96-well plate was seeded with
1  105 HEp-2 cells and inoculated onto HEp-2 cells followed by
incubation in 5% carbon dioxide at 37 C for 72 h. A positive cyto-
toxic effect was recorded as cell rounding under light microscopy.
The positive control of Cytotoxin-Producing K. oxytocaMH43-1 was
a gift from Dr Christoph Hoegenauer, Department of Internal
Medicine, Medical University of Graz, Austria. The K. oxytoca strain
ATCC 13182 served as negative control.
3. Results
A total of 75 isolates of K. oxytoca, 11 (14.7%) of isolates recovered
from blood, 2 (2.7%) of isolates recovered fromwounds, 4 (5.3%) of
isolates recovered from respiratory cultures, 51 (68%) of isolates
recovered from urine cultures and 7 (9.3%) of isolates recovered
from stool cultures.
In this study, all K. oxytoca strains isolated from stool cultures of
patients with diarrhea, and from urine, blood, wounds, and sputum
cultures were evaluated in terms of the production of cytotoxin by
HEp-2 cell culture. Of all the isolates, ﬁve K. oxytoca strains isolated
from the stool cultures, two strains isolated from the blood cul-
tures, one strain isolated from the wound cultures, and one strain
isolated from the urine cultures had cytotoxic effects on HEp-2 cells
(Fig. 1). The strains isolated from sputum cultures had no cytotoxic
effects on HEp-2 cells. The toxin-negative K. oxytoca ATCC13182
supernatants had no effects on HEp-2 cell cultures (Fig. 2).
4. Discussion
K. oxytoca is a commensal bacterium existing in the intestinal
ﬂora; it is present in the intestines of 2%e10% of healthy people [9].
However, this bacterium is introduced as an opportunistic path-
ogen, and nowadays it is considered as a clinically signiﬁcant
pathogen [1].
Cytotoxin is one of the important pathogenic factors, which
plays an important role in the virulence of this bacterium and is
associated with pathogenic effects of K. oxytoca [14].
The cytotoxic effects on epithelial cells of human are not
observed in other strains of Klebsiella spp and are only observed in
K. oxytoca strain. A part of the pathogenic effects of the bacteria is
attributed to the production of cytotoxin. The capacity of K. oxytoca
strains to produce toxins is a major factor in the pathogenesis of
Fig. 2. Cytotoxic effects of K. oxytoca supernatants strain isolated from patient on HEp-
2 cells.
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on laboratory animals such as mice, rat, rabbit, voles, and mole.
Darby et al. studied the cytotoxic and pathogenic characteristics of
K. oxytoca strains isolated from laboratory animals, including rats,
non-human primates, pigs, and guinea pig; the results of their
study, indicated that tilivalline was the cytotoxin present in these
strains [1].
Some studies in other countries have been conducted on toxi-
genic strains of K. oxytoca; according to their results, the prevalence
of toxigenic strains is reported between 23% and 82%. In this study
of 75 strains of K. oxytoca, nine strains (12%) were toxigenic. The
high prevalence of toxigenic strains of K. oxytoca in some studies
might be because the studied strains were isolated only from pa-
tients with antibiotic-associated hemorrhagic colitis (AAHC). Since,
cytotoxin is a major virulence factor which is involved in AAHC
progress and is associated with AAHC pathogenesis, the number of
toxigenic strains of K. oxytoca isolated from patients' samples is
usually higher. In this study, we used cell culture to study the
toxigenic effects of K. oxytoca strains isolated from urinary tract
infection, bacteremia, respiratory tract infection, diarrhea, colitis,
abscess, and wounds.
In this study, K. oxytoca strains isolated from stool cultures of
patients with diarrhea, and from urine, blood, wounds, and sputum
cultures were inestigate in terms of the production of cytotoxin by
HEp-2 cell culture. Of all the isolates, K. oxytoca strains isolated
from the stool, blood, wound, and urine cultures had cytotoxic ef-
fects on HEp-2 cells. The samples isolated from sputum cultures
had no cytotoxic effects. The majority of studies conducted in other
countries have assessed the toxigenic effects of K. oxytoca strains
isolated from patients with AAHC.
In a study by Joining et al., which was conducted in Austria in
2009, a total of 13 strains of K. oxytoca isolated from stool cultures
of healthy subjects, 10 strains isolated from urine cultures, 12
strains isolated from blood cultures,16 strains isolated fromwound,
15 strains isolated from patients with AAHC, and 14 strains isolated
from stool cultures of patients with diarrheawere assessed in terms
of cytotoxic effects on HEp-2 cells. Of all, six strains of K. oxytoca
isolated from stool cultures of healthy individuals, two strains
isolated from blood cultures, six strains isolated from wound cul-
tures, nine strains isolated from stool cultures of patients with
AAHC, and nine strains isolated from stool cultures of patients with
diarrhea had cytotoxic effects on HEp-2 cells. In strains isolatedfrom urine and sputum samples, no cytotoxic effect was observed.
According to the results of this study, the incidence of colitis was
attributed to the production of toxins, which was the result of
enormous growth of K. oxytoca strains isolated from patients and
healthy subjects undergoing antibiotic treatment [2].
Hogenauer et al., conducted a study on 22 patients with
Antibiotic-Associated Colitis (AAC) in Austria in 2006. Of the 22
patients, six patients were diagnosed with AAHC. K. oxytoca strains
were isolated from the stool cultures of ﬁve patients with AAHC; all
these isolates produced cytotoxin and had a cytotoxic effect on
HEp-2 cells [15].
In a study by Hoffmann et al., in Austria in 2010, K. oxytoca was
isolated from the stool culture of a 15-year-old male patient with
acute urinary infection who was affected by bloody diarrhea after
treating with amoxicillin and clavulanate. The K. oxytoca strain
produced cytotoxin and had cytotoxic effects on HEp-2 cells [11].
Ulbi et al., conducted a study in Australia in 2012 and evaluated
20 patients with AAHC diagnosed between 1996 and 2008. After
carrying out an assay for cytotoxic activity on the HEp-2 cells,
cytotoxic effects on HEp-2 cells were observed in 6 isolates of
K. oxytoca, which was due to the production of cytotoxin [16].
In a study by Tsang LL et al., which was conducted in Hong Kong
in 2011, a total of 6488 stool and rectal swab samples were collected
from 4170 patients with diarrhea who were hospitalized in the
general ward and bone marrow transplantation ward from October
2009 to November 2010. A total of 120 K. oxytoca isolates was
identiﬁed. Of all, 36 isolates of K. oxytoca (30%) were capable of
producing cytotoxin and had cytotoxic effects on HEp-2 cells. The
ﬁndings of this study showed that toxin-producing strains of
K. oxytoca were resistant to ampicillin and cephalothin [17].
In a study by Kathrin A. et al., which was conducted in Austria in
2013, of 74 strains of K. oxytoca collected in Germany, Spain, United
States of America, Hong Kong, Japan, Netherlands, and Austria, 39
isolates produced cytotoxin and had cytotoxic effects on HEp-
2 cells. Most of the toxin-producing strains were isolated from stool
samples of patients with AAHC, diarrhea, while a small number of
the strains were isolated from patients with colitis and asymp-
tomatic carriers [9].
Ines Zollner-Schwetz et al., conducted a study on 235 patients
with inﬂammatory bowel diseases (including 150 patients with
Crohn's disease and 85 patients with ulcerative colitis). They iso-
lated 11 strains of K. oxytoca. According to their ﬁndings, 2 isolates
produced tilivalline toxins on HEp-2 cells and rounded the cells and
showed cytopathic effects. In addition, of 12 asymptomatic intes-
tinal carriers, 4 isolates were toxigenic [7].
In a study by Alikhani. et al., which was conducted in Hamadan,
Iran fromMay 2011 to Dec 2013 faecal samples were collected from
hospitalized patients receiving antibiotic treatment. The clinical
isolates was cultured on Hep-2 cells for cytotoxin production. Out
of 331 samples collected from patients, 40 were conﬁrmed
molecularly to be clinical isolates of K. oxytoca. 40 isolated strains
showed cytotoxin activity on Hep-2 cells [18].
In most studies, K. oxytoca strains isolated from patients with
antibiotic-associated hemorrhagic colitis (AAHC) have been
assessed in terms of toxigenicity; in addition, these studies have
evaluated the role of these bacteria in the incidence of gastroin-
testinal infections. However, the use of clinical specimens other
than the stool is less studied. In this study, in addition to examining
the role of these bacteria in the incidence of gastrointestinal, role of
these bacteria in the incidence of urinary, respiratory, skin, and
bacteremia infections have evaluated, the K. oxytoca isolates were
also assessed in terms of toxigenicity. In our study, similar to other
studies, the majority of strains with cytopathic effects on HEp-
2 cells were isolated from the stool of the studied patients. In
conclusion, the majority of strains with cytopathic effects on HEp-
M. Validi et al. / Microbial Pathogenesis 113 (2017) 1e442 cells were isolated from the stool of the studied patients; as seen
in similar studies.
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